Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hi from BIO! I’m sitting in the frigid media room here next to STAT’s Brittany Trang, who is writing something scintillating about artificial intelligence.
Today, we’ve got Lilly chasing aesthetics with a AI-designed experimental hair loss drug from Absci, see a stark rise in the U.S. health care spending, and consider China’s ever-rising presence in biopharma.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
Visited 1 times, 1 visit(s) today
